Skip to content

Reliability of Community Ambulation Ability, Fall Risk, and Dynamic Visual Acuity Assessments in Stroke

Reliability of Community Ambulation Assessments, Taiwan Chinese Version of Falls Efficacy Scale, and Dynamic Visual Acuity Test in Individuals With Chronic Stroke

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07494487
Enrollment
30
Registered
2026-03-27
Start date
2026-04-01
Completion date
2028-07-31
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

fall risk, community ambulation, stroke, dynamic acuity, reliability

Brief summary

Nearly half of individuals with stroke experience limitations in community ambulation, and 35.7% of community-dwelling stroke survivors experienced falls while walking, indicating that falls are common during routine daily activities in community settings. Patla (1999) proposed that community mobility is influenced by eight factors: ambient conditions, terrain characteristics, external physical load, attentional demands, postural transitions, traffic level, time constraints, and walking distance. This framework suggests that community ambulation requires consideration of multiple physiological domains as well as environmental factors. However, current assessments of community ambulation primarily rely on indoor walking speed as an indicator, which may be insufficient to fully evaluate patients' community ambulation ability. Previous studies have not yet established the reliability of community ambulation assessments such as the Walking Ability Questionnaire, community walking speed, and the Falls Efficacy Scale (Taiwan Chinese version)-in individuals with chronic stroke. Additionally, stroke survivors often demonstrate insufficient integration of vestibular information, which may affect gait performance through impaired dynamic visual acuity. Therefore, this study aims to investigate the reliability of community ambulation assessments and dynamic visual acuity testing in individuals with chronic stroke.

Interventions

None listed

Sponsors

National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of First-occurrenced stroke * ≥ 6 months after stroke * Ability to walk at least 400 meters with or without the use of a walking assistive device * Mini-Mental State Examination score ≥ 24 * Age between 18 and 80 years

Exclusion criteria

* Other neurological or musculoskeletal conditions affected postural stability * Presence of dizziness or vertigo * Presence of conditions affecting cervical blood flow or limiting cervical range of motion * Visual impairment * Unstable cardiac status or uncontrolled hypertension

Design outcomes

Primary

MeasureTime frameDescription
Walking Ability QuestionnaireThe test will be conducted twice, with the second session scheduled 3-10 days after the first sessionWalking Ability Questionnaire consisting of 19 items related to daily walking activities to assess community ambulation
Community Walking SpeedThe test will be conducted twice, with the second session scheduled 3-10 days after the first sessionParticipants will complete an approximately 400-meter walking task
Taiwan Chinese Version of the Falls Efficacy ScaleThe test will be conducted twice, with the second session scheduled 3-10 days after the first sessionParticipants will rate their level of concern about falling while performing 16 activities using a 4-point Likert scale to evaluate fall risk
Dynamic Visual Acuity TestThe test will be conducted twice, with the second session scheduled 3-10 days after the first sessionUsing Dynamic Visual Acuity Test to evaluate vestibulo-ocular reflex function

Countries

Taiwan

Contacts

CONTACTYea-Ru Yang, PhD
yryang@nycu.edu.tw+886228267279

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026